Snehal International Pharma Private Limited
About Snehal International Pharma Private Limited
Data last updated:
Snehal International Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 04 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC345294.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mrudula Sudhir Deulgaonkar and Sudhir Ravindra Deulgaonkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 101 Flr – 1st Plot No.163E Vasant Kunj Dr. Babasaheb Ambedkar Road Dadar(E), Mumbai, Maharashtra, India – 400014.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.15 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.69 Lakh (net margin -320.5%) and EBITDA of -₹3.69 Lakh (EBITDA margin -320.5%). Revenue has declined at a compounded annual rate (CAGR) of 57% over three years.
Company details
Contact details
Snehal International Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressE – 101 Flr – 1st Plot No.163E Vasant Kunj Dr. Babasaheb Ambedkar Road Dadar(E), Mumbai, Maharashtra, India – 400014
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Snehal International Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Snehal International Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Snehal International Pharma Private Limited, buy the company report.
Financials of Snehal International Pharma Private Limited
FY 2025 filings availableSnehal International Pharma Private Limited reported revenue of ₹1.15 Lakh (up 304% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 304% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 57%. EBITDA fell 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -320.5% | ||||
| Net Profit Margin | -320.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Snehal International Pharma Private Limited, buy the company report.
Board of directors of Snehal International Pharma Private Limited
Snehal International Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mrudula Sudhir Deulgaonkar | Director | 04 Sep 2020 | 6 Years 2 Months | Current |
| Sudhir Ravindra Deulgaonkar Also directs: Snehal Pharma & Surgicals Private Limited | Director | 04 Sep 2020 | 6 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Snehal International Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Snehal International Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Snehal International Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Snehal International Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Mrudula Sudhir Deulgaonkar was appointed as Director on 04 Sep 2020.
Frequently asked questions
Snehal International Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 04 September 2020 (6+ years old) and is registered under CIN U24290MH2020PTC345294.
Snehal International Pharma has 2 current directors:
- Mrudula Sudhir Deulgaonkar - Director
- Sudhir Ravindra Deulgaonkar - Director
The latest financial statements of Snehal International Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Snehal International Pharma is U24290MH2020PTC345294. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Snehal International Pharma was incorporated on 04 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Mrudula Sudhir Deulgaonkar was appointed as Director on 04 Sep 2020. Sudhir Ravindra Deulgaonkar was appointed as Director on 04 Sep 2020.
The registered office of Snehal International Pharma is at E – 101 Flr – 1st Plot No.163E Vasant Kunj Dr. Babasaheb Ambedkar Road DadarE, Mumbai, Maharashtra, India – 400014.
Snehal International Pharma operates in the pharma industry, in the pharma contract r and d segment.
Snehal International Pharma can be reached at its registered office: E – 101 Flr – 1st Plot No.163E Vasant Kunj Dr. Babasaheb Ambedkar Road DadarE, Mumbai, Maharashtra, India – 400014.
Snehal International Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
